痉咳静治疗小儿百日咳综合征痰热伏肺证59例

摘要

目的 评价痉咳静治疗小儿百日咳综合征痰热伏肺证的临床疗效.方法 以罗红霉素为对照(29例),进行痉咳静治疗小儿百日咳综合征痰热伏肺证(59例)的有效性和安全性的随机、平行对照的临床研究.结果 试验组痊愈率为50.50％,痊愈显效率为81.54％；对照组痊愈率为30.61％,痊愈显效率为70.34％.痉咳静疗效显著优于对照组(P＜0.01).结论 痉咳静是治疗小儿百日咳综合征痰热伏肺证的有效而安全的药物.%OBJECTIVE To evaluate the therapeutic effects of Jingkejing on children's whooping cough belonging to the syndrome of phlegm-heat hidden in the lung. METHODS Clinical study with random and parallel control into the efficacy and safety of 59 cases given Jingkejing was carried out by comparing 29 cases taking roxithromycin. RESULTS The recovery rate and markedly effective rate of experimental group were 50.50% and 81.54% respectively; while those of control group were 30.61 % and 70.34%. Apparently, the therapeutic effects of Jingkejing group were superior to control group. CONCLUSION Jingkejing is considered as the effective and safe drug for the treatment of children's whooping cough belonging to the syndrome of phlegm-heat hidden in the lung.